title: Lymphocyte content of amyloid precursor protein is increased in Down's syndrome and aging.
abstract: We quantified cellular amyloid precursor protein (APP) in ethanol-permeabilized peripheral lymphocytes from 13 subjects with Alzheimer's disease (AD), 11 subjects with Down's syndrome (DS), and 13 healthy elderly and 31 healthy young controls. APP content was analyzed by indirect immunofluorescence and flow cytometry, using the 22C11 monoclonal antibody (mAb) directed against an N-terminal domain of APP. Authenticity of 22C11 APP signal was confirmed by immunoblotting and flow cytometry studies with the mAb 6E10, directed against the A beta domain of APP. Consistent with gene dosage, patients with DS had 1.51-fold higher lymphocyte APP signal than age-matched normal young subjects (corrected p < 0.05). Both AD patients and elderly control groups had significantly increased lymphocyte APP signal compared to young controls (either comparison corrected p < 0.01). Indeed, increasing age in non-DS subjects was significantly correlated with lymphocyte APP (r = 0.508, p < 0.0001), such that APP immunoreactivity more than doubled from 20 to 80 years. Lymphocyte APP was nonsignificantly higher in AD vs. aged controls in this small sample. Increased cellular APP content in DS and aging may correspond to generalized alterations in expression or processing of this molecule, and suggests a novel determinant for the timing of AD onset.
authors.affiliation: Department of Microbiology and Immunology, McGill Centre for Studies in Aging, McGill University, Montréal, Canada.
authors.forename: C
authors.initials: C
authors.lastname: Pallister
authors.forename: S S
authors.initials: SS
authors.lastname: Jung
authors.forename: I
authors.initials: I
authors.lastname: Shaw
authors.forename: J
authors.initials: J
authors.lastname: Nalbantoglu
authors.forename: S
authors.initials: S
authors.lastname: Gauthier
authors.forename: N R
authors.initials: NR
authors.lastname: Cashman
mesh_terms: D000328:Adult; D000368:Aged; D000375:Aging / Q000097:blood*; D000544:Alzheimer Disease / Q000097:blood; D016564:Amyloid beta-Protein Precursor / Q000097:blood*; D002492:Central Nervous System Depressants / Q000494:pharmacology; D004314:Down Syndrome / Q000097:blood*; D000431:Ethanol / Q000494:pharmacology; D005434:Flow Cytometry; D019084:Fluorescent Antibody Technique, Indirect; D006801:Humans; D015151:Immunoblotting; D008214:Lymphocytes / Q000378:metabolism*
chemical_list: D016564:Amyloid beta-Protein Precursor; D002492:Central Nervous System Depressants; D000431:Ethanol